Sign in
RSPI Stock Price, Chart, Stats & News
RespireRx Pharmaceuticals Inc.
Save
RespireRx Pharmaceuticals Inc. (RSPI) does not currently pay a dividend.
657,754
Market cap
–
Current P/E
–
Forward P/E
RSPI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
RespireRx Pharmaceuticals Inc. is dedicated to researching, developing, and commercializing pharmaceutical products aimed at addressing neurological and psychiatric conditions. The company operates through two primary therapeutic platforms: ResolutionRx, which investigates pharmaceutical cannabinoids, and EndeavourRx, focused on neuromodulators. The ResolutionRx platform encompasses cannabinoids such as dronabinol, a compound that interacts with CB1 and CB2 endocannabinoid receptors.
Similar securities
Based on sector and market capitalization
Report issue